Perkins Coie is pleased to announce that Alex (Kwan-Ho) Chung, Ph.D., has joined the firm’s Intellectual Property practice as a partner in the Patent Prosecution & Portfolio Counseling subgroup of the Washington, D.C., office. Alex is the latest addition to the firm’s growing Intellectual Property team on the East Coast, which has recently added partners Ngai Zhang, Drew Schulte, and Lori Gordon. Alex joins Perkins Coie from Jones Day, where he was a member of the intellectual property and Korea practices.
Alex focuses his practice on representing U.S., European, Korean, and Japanese companies in the biotechnology, pharmaceutical, chemical, and medical device industries. Alex has extensive experience providing strategic IP counsel to his clients in the areas of procuring, managing, evaluating, enforcing, and defending patents. Additionally, he is skilled at navigating multi-jurisdictional patent protection.
“Alex’s legal talents and technical experience representing life sciences clients in highly technical transactions make him a valuable addition to our practice,” said David Fournier, firmwide chair of Perkins Coie’s Patent Prosecution & Portfolio Counseling practice. “As a U.S. patent co-inventor with a Ph.D. in neuroscience, he has a deep personal understanding of patent protection and the myriad complexities of our clients’ portfolios and work.”
Alex’s practice also includes providing patentability, infringement, validity, and freedom-to-operate opinions, and conducting due diligence analysis on IP portfolios. He is a co-inventor of a U.S. patent on microRNA-based RNA interference (RNAi) expression vector.
“Washington, D.C., is a key market for patent prosecution, and Alex’s addition further builds out our capabilities for the East Coast and beyond. We’re excited that Alex is joining our growing team,” said Val Dahiya, Perkins Coie’s Washington, D.C., office managing partner.
Alex received his J.D. from the George Washington University Law School, his Ph.D. in neuroscience from the University of Michigan Medical School, his M.S. in immunology and genetic engineering from Seoul National University, and his B.S. in microbiology from Seoul National University.
